Related Experiment Video
Updated: Apr 6, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Notch Signaling in Cancer: Rationale and Strategies for Targeting
1Department of Pharmacology & Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates. samir.attoub@uaeu.ac.ae.
Abstract:
The Notch signaling pathway is a highly conserved system that controls embryonic cell fate decisions and the maintenance of adult stem cells through affecting communication between adjacent cells. The pathway is linked to the development of various cancers owing to increased cell proliferation and tumor blood perfusion in addition to inhibition of apoptosis. Pharmaceutical agents that suppress overactive Notch signaling may be of benefit in the treatment of patients with various cancers. These targeted therapies confer several advantages over conventional anticancer therapies including reduced deleterious effects on normal cells. In this review, we explore the rationale for targeting the Notch signaling pathway in cancer along with different investigational strategies designed to block the pathway.
Insights
The Notch signaling pathway regulates cell fate and stem cells. Suppressing this pathway offers targeted cancer therapy with fewer side effects than traditional treatments.
Area of Science:
- Cell biology
- Developmental biology
- Cancer biology
Background:
- The Notch signaling pathway is crucial for cell fate determination and stem cell maintenance.
- Aberrant Notch signaling is implicated in various cancers, promoting proliferation and angiogenesis.
- Targeting Notch signaling presents a promising strategy for cancer treatment.
Purpose of the Study:
- To review the rationale for targeting the Notch signaling pathway in cancer.
- To explore investigational strategies for blocking Notch signaling in cancer therapy.
Main Methods:
- Literature review of Notch signaling in cancer.
- Analysis of targeted therapeutic strategies.
Main Results:
- Notch pathway dysregulation contributes to cancer development.
- Targeted therapies inhibiting Notch signaling show potential advantages over conventional treatments.
- Several investigational strategies exist to block the Notch pathway.
Conclusions:
- Targeting the Notch signaling pathway is a rational approach for cancer treatment.
- Investigational therapies offer a promising avenue for managing various cancers with potentially reduced toxicity.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

